Community acquired pneumonia

Search with Google Search with Bing
Information
Disease name
Community acquired pneumonia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00079885 Completed Phase 3 Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia November 2003 July 2005
NCT01228110 Completed N/A Corticosteroids in Community Acquired Pneumonea
NCT01336036 Completed Causes and Outcomes of Community Acquired Pneumonia February 2011 February 2014
NCT01420744 Completed Phase 2 Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP August 2011 April 2015
NCT01530763 Completed Phase 2/Phase 3 Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP) September 2012 July 2014
NCT01561885 Completed N/A Collaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways March 2012 March 2016
NCT01661920 Completed N/A Suitability of Antibiotic Treatment for CAP January 2012 April 2014
NCT01787838 Completed N/A Improving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting January 2013 January 2014
NCT01875731 Completed N/A Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine July 2013 July 2014
NCT01883869 Completed Phase 1 Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor June 2013 June 2016
NCT01886053 Completed Phase 2 A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia April 2011 July 2012
NCT01963000 Completed Standardized Emergency Care for Community Acquired Pneumonia (CAP) January 2007 December 2012
NCT01964495 Completed N/A Reduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study) December 5, 2013 January 20, 2017
NCT02107001 Completed Lung Ultrasound in Pleuritic Chest Pain March 2014 November 2015
NCT02427048 Completed N/A Clinical Practice Guidelines and Impact of Audit and Feedback in the Emergency Department July 2015 December 2016
NCT02454114 Completed N/A HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections October 2013 January 2015
NCT02517489 Completed Phase 3 Community-Acquired Pneumonia : Evaluation of Corticosteroids October 28, 2015 August 28, 2020
NCT02559310 Completed Phase 3 Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia September 2015 May 2017
NCT02813694 Completed Phase 3 Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia August 2016 January 2018
NCT02880384 Completed N/A Pathogen Detection and Community Acquired Pneumonia January 2017 December 20, 2020
NCT02922387 Completed Phase 4 Smoking Cessation Intervention in Respiratory Inpatients May 2012 May 2015
NCT02963142 Completed A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia December 2016 October 2018
NCT03411824 Completed Lung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine November 8, 2016 February 8, 2019
NCT03475732 Completed N/A Pharmacokinetics of XueBiJing in Patients With Sepsis March 18, 2018 December 31, 2019
NCT04198571 Completed Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries May 17, 2020 August 30, 2021
NCT00467701 Completed Community Acquired Pneumonia in Telemark and Ostfold May 2007 February 2008
NCT00646490 Completed Pleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural Effusion July 2005 July 2009
NCT00653172 Completed Phase 2 Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia October 2007 November 2008
NCT00929721 Completed N/A A Global Active Surveillance for Community Acquired Pneumonia December 2009 February 2012
NCT01071421 Completed Sleep Apnea Syndrome and Community Acquired Pneumonia April 2006 December 2008
NCT06220019 Not yet recruiting REspiratory diSEAse cohoRt Studies of CHinese Medicine for CAP (RESEARCH- CAP) April 2024 March 2026
NCT06210282 Recruiting N/A The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice November 3, 2023 September 1, 2024
NCT01081964 Terminated Phase 2 Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia March 2010 June 2012
NCT00492271 Terminated Phase 1 First Time in Man Trial for Friulimicin B June 2007 September 2007
NCT00887276 Terminated Phase 4 Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia November 2008 January 2011
NCT02775968 Unknown status Population Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneumonia June 21, 2017 October 2022
NCT03146182 Unknown status N/A Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia March 15, 2017 February 2019
NCT02139163 Unknown status Epidemiological Study on Community Acquired Pneumonia October 2002 January 2022
NCT01236677 Unknown status The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing August 2010 December 2011
NCT02203110 Unknown status The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia January 2014 March 2016
NCT02224716 Unknown status Multicenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospitals July 2014 December 2015
NCT00258869 Unknown status Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests December 2005 July 2010
NCT00270517 Unknown status Phase 2 Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia December 2005 July 2007
NCT00390819 Unknown status Epidemiology of Community Acquired Pneumonia in North Israel November 2006
NCT04158310 Unknown status Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Children November 11, 2019 March 1, 2021
NCT01963442 Unknown status Phase 2 Short Duration Treatment of Non-severe Community Acquired Pneumonia November 2013 June 2018
NCT02492425 Unknown status A Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of China January 2016 May 2018
NCT02552342 Unknown status Phase 4 Corticosteroid Therapy for Severe Community-Acquired Pneumonia May 2015 May 2017
NCT01937832 Unknown status Phase 3 A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia October 2013
NCT02913118 Unknown status Phase 4 Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia July 2016 June 30, 2019
NCT02489578 Unknown status A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China) July 2015 December 2016
NCT02269644 Withdrawn Phase 3 A P3 Comparator Trial in Community Acquired Bacterial Pneumonia November 2015 December 2016
NCT02139384 Withdrawn Clinical Pediatric Pneumonia Score in Critically Ill Children August 2012 January 2013
NCT00946166 Withdrawn Phase 4 Impact of Statins on Cytokine Expression in Pneumonia July 2009 August 2011
MedGen concept unique identifier (MedGen Concept name)
C0694549
MedGen unique identifier (MedGen Concept name)
675054